SPIKEVAX LP.8.1 Moderna Australia Pty Ltd
Product name
SPIKEVAX LP.8.1
Sponsor
Accepted date
Dec-2025
Active ingredients
SARS-CoV-2 LP.8.1 mRNA
Proposed indication
SPIKEVAX LP.8.1 (SARS-CoV-2 LP.8.1 mRNA) COVID-19 Vaccine is proposed for active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 12 years of age and older.
Application type
A (new medicine)
Publication date
Dec-2025